A 55-year-old woman with locally advanced rectal cancer and a resectable synchronous hepatic metastasis: a case report

This publication has 18 references indexed in Scilit:

• Multicenter phase II study of second-line bevacizumab plus doublet combination chemotherapy in patients with metastatic colorectal cancer progressed after upfront bevacizumab plus doublet combination chemotherapy
  Investigational New Drugs, 2012
• Is Perioperative Chemotherapy Useful for Solitary, Metachronous, Colorectal Liver Metastases?
  Annals of Surgery, 2010
• Prognostic Factors for Recurrence After Pulmonary Resection of Colorectal Cancer Metastases
  The Annals of Thoracic Surgery, 2009
• Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE)
  Journal of Clinical Oncology, 2008
• Liver Surgery for Colorectal Metastases: Results after 10 Years of Follow-Up. Long-Term Survivors, Late Recurrences, and Prognostic Role of Morbidity
  Annals of Surgical Oncology, 2008
• Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
  The Lancet, 2008
• Adjuvant Chemotherapy Improves Survival after Resection of Hepatic Colorectal Metastases: Analysis of Data from Two Continents
  Journal of the American College of Surgeons, 2007
• Clinicopathological Features and Prognosis in Resectable Synchronous and Metachronous Colorectal Liver Metastasis
  Annals of Surgical Oncology, 2006
• Multicenter Randomized Trial of Adjuvant Fluorouracil and Folinic Acid Compared With Surgery Alone After Resection of Colorectal Liver Metastases: FFCD ACHBTH AURC 9002 Trial
  Journal of Clinical Oncology, 2006
• Intraoperative presacral electron boost following preoperative chemoradiation in T3–4Nx rectal cancer: initial local effects and clinical outcome analysis
  Radiotherapy and Oncology, 2002